La Fauce Kathy, Owens Leigh
Microbiology and Immunology, School of Veterinary and Biomedical Science, James Cook University, Townsville, QLD 4811 Australia.
Indian J Virol. 2012 Sep;23(2):226-43. doi: 10.1007/s13337-012-0084-1. Epub 2012 Aug 14.
RNA interference has evolved from being a nuisance biological phenomenon to a valuable research tool to determine gene function and as a therapeutic agent. Since pioneering observations regarding RNA interference were first reported in the 1990s from the nematode worm, plants and Drosophila, the RNAi phenomenon has since been reported in all eukaryotic organisms investigated from protozoans, plants, arthropods, fish and mammals. The design of RNAi therapeutics has progressed rapidly to designing dsRNA that can specifically and effectively silence disease related genes. Such technology has demonstrated the effective use of short interfering as therapeutics. In the absence of a B cell lineage in arthropods, and hence no long term vaccination strategy being available, the introduction of using RNA interference in crustacea may serve as an effective control and preventative measure for viral diseases for application in aquaculture.
RNA干扰已从一种令人讨厌的生物学现象演变成一种用于确定基因功能的有价值的研究工具以及一种治疗剂。自20世纪90年代首次在线虫、植物和果蝇中报道有关RNA干扰的开创性观察结果以来,RNAi现象此后已在从原生动物、植物、节肢动物、鱼类到哺乳动物等所有被研究的真核生物中被报道。RNAi疗法的设计已迅速发展到设计能够特异性且有效地沉默疾病相关基因的双链RNA。此类技术已证明短干扰RNA作为治疗剂的有效应用。由于节肢动物中不存在B细胞谱系,因此没有可用的长期疫苗接种策略,在甲壳类动物中引入RNA干扰可能作为水产养殖中病毒性疾病的有效控制和预防措施。